Picard Medical, Inc.
PMI
$9.73
-$0.57-5.53%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 207.06% | -68.69% | 1.21% | -2.22% | -63.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 207.06% | -68.69% | 1.21% | -2.22% | -63.40% |
| Cost of Revenue | 109.85% | -16.62% | -63.86% | 17.73% | -56.84% |
| Gross Profit | 66.75% | -144.36% | 112.24% | -60.62% | 36.01% |
| SG&A Expenses | 5.96% | 4.58% | -30.81% | 18.67% | 35.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.10% | 0.36% | -34.56% | 24.77% | -6.69% |
| Operating Income | 7.92% | -73.40% | 39.56% | -31.99% | -29.80% |
| Income Before Tax | -65.74% | -183.01% | -47.70% | -88.86% | -38.13% |
| Income Tax Expenses | -- | -- | -650.00% | -- | -- |
| Earnings from Continuing Operations | -65.74% | -184.60% | -47.50% | -88.86% | -38.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.74% | -184.60% | -47.50% | -88.86% | -38.13% |
| EBIT | 7.92% | -73.40% | 39.56% | -31.99% | -29.80% |
| EBITDA | 8.97% | -85.20% | 38.78% | -36.58% | -36.47% |
| EPS Basic | -43.41% | -141.60% | -43.18% | -77.12% | -33.70% |
| Normalized Basic EPS | -49.22% | -182.37% | -47.71% | -88.90% | -38.12% |
| EPS Diluted | -43.41% | -141.60% | -43.18% | -77.12% | -33.70% |
| Normalized Diluted EPS | -49.22% | -182.37% | -47.71% | -88.90% | -38.12% |
| Average Basic Shares Outstanding | 11.07% | 0.25% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 11.07% | 0.25% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |